These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 7677978

  • 1. Cytokeratins in normal thymus and thymic epithelial tumors.
    Fukai I, Masaoka A, Hashimoto T, Yamakawa Y, Mizuno T, Tanamura O.
    Cancer; 1993 Jan 01; 71(1):99-105. PubMed ID: 7677978
    [Abstract] [Full Text] [Related]

  • 2. Cytokeratin profiles of the thymus and thymomas: histogenetic correlations and proposal for a histological classification of thymomas.
    Kuo Tt.
    Histopathology; 2000 May 01; 36(5):403-14. PubMed ID: 10792481
    [Abstract] [Full Text] [Related]

  • 3. Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile.
    Kuo TT, Chan JK.
    Am J Surg Pathol; 1998 Dec 01; 22(12):1474-81. PubMed ID: 9850173
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunohistochemical studies on a human thymic epithelial cell subset defined by the anti-cytokeratin 18 monoclonal antibody.
    Savino W, Dardenne M.
    Cell Tissue Res; 1988 Oct 01; 254(1):225-31. PubMed ID: 2461804
    [Abstract] [Full Text] [Related]

  • 6. An immunohistochemical study of thymic epithelial tumors. I. Epithelial component.
    Kodama T, Watanabe S, Sato Y, Shimosato Y, Miyazawa N.
    Am J Surg Pathol; 1986 Jan 01; 10(1):26-33. PubMed ID: 2420219
    [Abstract] [Full Text] [Related]

  • 7. An immunohistologic study of the epithelial components of 81 cases of thymoma.
    Fukai I, Masaoka A, Hashimoto T, Yamakawa Y, Mizuno T, Tanamura O, Hirokawa K, Ueda R.
    Cancer; 1992 May 15; 69(10):2463-8. PubMed ID: 1373667
    [Abstract] [Full Text] [Related]

  • 8. [Thymomas and thymic carcinomas].
    De Montpréville VT.
    Rev Mal Respir; 2010 Dec 15; 27(10):1281-7. PubMed ID: 21163404
    [No Abstract] [Full Text] [Related]

  • 9. Immunohistological analysis of thymoma by molecules differentially expressed in the thymic cortex and medulla, and its application in the differential diagnosis of thymoma from esophageal and lung cancer.
    Shiraishi J, Utsuyama M, Akashi T, Nemoto T, Ohashi K, Akamatsu H, Sunamori M, Kitagawa M, Hirokawa K.
    Pathol Res Pract; 2001 Dec 15; 197(9):611-9. PubMed ID: 11569925
    [Abstract] [Full Text] [Related]

  • 10. The clinicopathological significance of thymic epithelial markers expression in thymoma and thymic carcinoma.
    Li H, Ren B, Yu S, Gao H, Sun PL.
    BMC Cancer; 2023 Feb 16; 23(1):161. PubMed ID: 36797681
    [Abstract] [Full Text] [Related]

  • 11. [Pattern of intermediate filaments in thymomas].
    Dirsch OR, Odermatt BF, Scherrer C, Heitz PU.
    Verh Dtsch Ges Pathol; 1990 Feb 16; 74():424-8. PubMed ID: 1708630
    [Abstract] [Full Text] [Related]

  • 12. Desmoglein 3 and p40 immunoreactivity in neoplastic and nonneoplastic thymus: a potential adjunct to help resolve selected diagnostic and staging problems.
    Walts AE, Hiroshima K, Marchevsky AM.
    Ann Diagn Pathol; 2015 Aug 16; 19(4):216-20. PubMed ID: 25979154
    [Abstract] [Full Text] [Related]

  • 13. Thymomas and thymic carcinomas.
    Walker AN, Mills SE, Fechner RE.
    Semin Diagn Pathol; 1990 Nov 16; 7(4):250-65. PubMed ID: 2284513
    [Abstract] [Full Text] [Related]

  • 14. Differential diagnosis of thymic carcinoma and lung carcinoma with the use of antibodies to cytokeratins.
    Fukai I, Masaoka A, Hashimoto T, Yamakawa Y, Niwa H, Kiriyama M, Eimoto T.
    J Thorac Cardiovasc Surg; 1995 Dec 16; 110(6):1670-5. PubMed ID: 8523878
    [Abstract] [Full Text] [Related]

  • 15. The distribution of epithelial membrane antigen in thymic epithelial neoplasms.
    Fukai I, Masaoka A, Hashimoto T, Yamakawa Y, Mizuno T, Tanamura O.
    Cancer; 1992 Oct 15; 70(8):2077-81. PubMed ID: 1394038
    [Abstract] [Full Text] [Related]

  • 16. PE-35-related antigen expression and CD1a-positive lymphocytes in thymoma subtypes based on Müller-Hermelink classification. An immunohistochemical study using catalyzed signal amplification.
    Hattori H, Tateyama H, Tada T, Saito Y, Yamakawa Y, Eimoto T.
    Virchows Arch; 2000 Jan 15; 436(1):20-7. PubMed ID: 10664158
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical differentiation between type B3 thymomas and thymic squamous cell carcinomas.
    Su XY, Wang WY, Li JN, Liao DY, Wu WL, Li GD.
    Int J Clin Exp Pathol; 2015 Jan 15; 8(5):5354-62. PubMed ID: 26191237
    [Abstract] [Full Text] [Related]

  • 18. Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma.
    Pan CC, Chen PC, Chou TY, Chiang H.
    Hum Pathol; 2003 Nov 15; 34(11):1155-62. PubMed ID: 14652817
    [Abstract] [Full Text] [Related]

  • 19. An immunohistologic study of the epithelial and lymphoid components of six thymomas.
    van der Kwast TH, van Vliet E, Cristen E, van Ewijk W, van der Heul RO.
    Hum Pathol; 1985 Oct 15; 16(10):1001-8. PubMed ID: 2412943
    [Abstract] [Full Text] [Related]

  • 20. Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus.
    Marino M, Müller-Hermelink HK.
    Virchows Arch A Pathol Anat Histopathol; 1985 Oct 15; 407(2):119-49. PubMed ID: 3927579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.